David Brennan of AstraZeneca says public sector crucial to drug research
AstraZeneca’s chief executive will this week urge ministers to work with the pharmaceutical industry to share the risks and costs
AstraZeneca’s chief executive will this week urge ministers to work with the pharmaceutical industry to share the risks and costs
The U.S. Food and Drug Administration today announced the award of $2.9 million to support six research projects that will
The 4th Open Forum Conference was held in Addis Ababa, Ethiopia on 18th and 19th August to address key issues
[New York, United States and Geneva, Switzerland, July 7, 2010] The Global Alliance for TB Drug Development (TB Alliance) and
Compounds being developed against tuberculosis also show promise against deadly tropical diseases threatening millions of people, two not-for-profits groups said
Better drugs and understanding should see tuberculosis treated like any other respiratory disease in future, the TB Alliance said in
Members of Parliament from Spain and other European nations, along with international activists, researchers and NGOs met at the Spanish
According to a paper published today in The Lancet, there is unprecedented progress in the development of the global tuberculosis
LONDON – Multi-drug resistant strains of tuberculosis (TB) could become dominant forms of the disease in the next few decades,
New York and Bangalore, India, May 3, 2010 – The Global Alliance for TB Drug Development (TB Alliance) and AstraZeneca